Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Share News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma

Mon, 01st Mar 2021 16:41

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

Sensyne Health PLC - Oxford, England-based clinical technology using artificial intelligence - Moves Chief Investment Officer Richard Pye to chief financial officer and executive director, while interim CFO Michael Norris moves to non-executive director, both from last Friday. Norris has been interim CFO since March last year. Additionally, Geoff Race joins the board as non-executive director. Race is co-founder and CFO of Nasdaq-listed biopharmaceutical company Minerva Neurosciences Inc.

----------

Focusrite PLC - High Wycombe, Buckinghamshire-based music and audio products - Sally McKone joins board and takes over as CFO on Monday, replacing Jeremy Wilson. McKone's appointment was announced back in September. McKone was divisional finance and IT director for Precision Engineering, the largest subsidiary of IMI PLC.

----------

Bango PLC - Cambridge, England-based e-commerce platform - Hires Matt Garner as CFO and board member, effective immediately. Garner joins from satellite communications technology firm Global Invacom Group Ltd. Garners departure from AIM-listed Global Invacom was announced back in December. The Singapore-based company, which reported 2020 results on Monday, says it has no current intention to appoint a new CFO, with its two financial controllers running finance instead. Bango says Garner replaces Carolyn Rand, who steps down as CFO and from the board but will remain as a consultant for the coming year. Rand was hired as interim CFO in October 2018 and became full-time CFO in January 2019. Bango will publish its 2020 results on March 16.

----------

4D Pharma PLC - Leeds-based live biotherapeutic products developer - Appoints John Beck, most recently chief financial officer at Ritter Pharmaceuticals Inc, as its own CFO. Beck oversaw Ritter's merger with Qualigen Therapeutics Inc, completed in May last year. Also hires Paul Maier as non-executive director. Maier was CFO of Sequenom Inc and of Nasdaq-listed Ligand Pharmaceuticals Inc.

----------

TBC Bank Group PLC - financial services in Georgia and Uzbekistan - Nikoloz Enukidze steps down as chair of board of TBC Bank Group PLC and of the supervisory board of TBC Bank JSC, effective immediately. Senior Independent Director Arne Berggren will take over both chairs, and Tsira Kemularia is promoted to interim senior independent director. Enukidze will remain for now a member of both boards but won't seek re-election at the 2021 annual general meeting. Nicholas Haag and Eric Rajendra also will step down as non-executive directors at the AGM.

----------

Herald Investment Trust PLC - invests for capital gains from smaller technology, communications and multi-media stocks - Chair Ian Russell resigns from board effective immediately "for personal reasons". Senior Independent Director Tom Black, on the board since 2013, succeeds Russell as chair.

----------

e-Therapeutics PLC - Oxford, England-based drug discovery using computers - Splits role of executive chair and chief executive, effective immediately. Independent Non-Executive Director Trevor Jones becomes non-executive chair, while Ali Mortazavi continues as CEO. Seeking additional non-executive director for board.

----------

Informa PLC - London-based business media, training and events - Senior Independent Director Gareth Bullock to step down from board at June AGM, having served for seven years. Meanwhile, Chief Operating Officer Patrick Martell joins the board on Monday as an executive director. Martell also is a non-executive director of education technology firm RM PLC.

----------

MJ Gleeson PLC - Sheffield-based housebuilder - Hires Elaine Bailey as non-executive director starting Monday. Until 2019, Bailey was chief executive of Hyde Housing Group, a London-based housing association with 50,000 properties. Bailey also is a non-executive director of Residential Secure Income PLC.

----------

Just Group PLC - Surrey, England-based retirement income products provider - Hires Kalpana Shah as non-executive director, starting Monday. Kalpana is a 30-year veteran of the insurance and investment industry, Just Group says. She was chief actuary and a partner at Hiscox Ltd until 2016.

----------

Ferrexpo PLC - Baar, Switzerland-based iron-ore miner in Ukraine - Hires Ann-Christin Andersen as independent non-executive director. Anderson was chief digital officer of energy technology and services firm TechnipFMC and managing director of TechnipFMC Norway. Anderson also is a non-executive director of flow control and instrumentation firm Rotork PLC.

----------

AdEPT Technology Group PLC - information technology provider based in London - Says by mutual consent will not re-appoint Christopher Kingsman as non-executive director. Back in February, AdEPT had said Kingsman would rejoin the board starting March 1.

----------

First Derivatives PLC - Newry, Northern Ireland-based consulting and software for finance, automotive and energy industries - Hires Scott Matthews as CEO for predictive intelligence business MRP. Matthews joins from Crowdtwist, a customer loyalty solutions provider that was acquired by Oracle Corp. He replaces MRP Co-Founder Kevin Cunningham, who steps down after 13 years as CEO. First Derivatives also hires Eric Raab to be chief technology officer of analytics software business KX. Raab joins on Monday from Information Builders Inc, a data and analytics software company where he also was CTO. Both roles report to First Derivatives CEO Seamus Keating.

----------

Horizonte Minerals PLC - nickel mines in Brazil - Hires Michael Drake as head of Projects to oversee the development of Horizonte's two wholly owned projects, the Araguaia ferro-nickel project and the Vermelho nickel-cobalt project, both in Brazil. Drake will be based at Horzonte's Brazilian headquarters in Belo Horizonte. He is a mechanical engineer who previously worked at BHP Group PLC and Newcrest Mining Ltd.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
15 Feb 2023 14:21

IN BRIEF: 4D Pharma shares cancelled from trading on London's AIM

4D Pharma PLC - Leeds-based pharmaceutical firm - Notes cancellation of its shares on AIM from Thursday, after it entered into administration in June 2022.

Read more
3 Feb 2023 15:17

TRADING UPDATES: GCP Infra hails NAV rise; Jadestone profits from oil

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
9 Jan 2023 15:58

UK shareholder meetings calendar - next 7 days

Tuesday 10 January 
Valereum Blockchain PLCAGM
Wishbone Gold PLCAGM
Wednesday 11 January 
AB Dynamics PLCAGM
Asos PLCAGM
Edge Performance VCT PLCGM re deed of release
Hurricane Energy PLCAGM
Induction Healthcare Group PLCAGM
MetalNRG PLCGM requisitioned to remove chair and CEO from board
Synthomer PLCGM re sale of laminates business
Thursday 12 January 
JPMorgan Japanese Investment Trust PLCAGM
Friday 13 January 
eEnergy Group PLCGM re shareholder resolution to adopt the 2022 Accounts
Monday 16 January 
4D Pharma PLCGM re update on administration and suspension of trading
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
30 Dec 2022 17:21

4D Pharma seeks approval for equity fundraise to lift suspension

(Alliance News) - 4D Pharma PLC on Friday said it was seeking shareholder approval for a USD15.0 million cash raise, as it works to lift its suspension and restore its shares to trading.

Read more
16 Nov 2022 17:00

4D Pharma says trial results show Blautix eases IBS symptoms

(Alliance News) - 4D Pharma PLC said on Wednesday that its Blautix phase 2 clinical trial results showed the treatment had a positive effect on sufferers of irritable bowel syndrome

Read more
24 Aug 2022 11:44

IN BRIEF: 4D Pharma publishes pre-clinical research for autism

4D Pharma PLC - Leeds, England-based pharmaceutical company - Releases its publication of pre-clinical research on mice regarding live biotherapeutic MRx0006 for the treatment of autism spectrum disorder. Says research shows LBP MRx0006 can attenuate core behavioural deficits in a mouse model of autism, improving social deficits, repetitive and anxiety-like behaviours. "Mechanistically, MRx0006 increased in the brains of ASD mice the expression of neuropeptide hormones known to regulate social and anxiety behaviour," 4D Pharma adds.

Read more
5 Aug 2022 14:58

TRADING UPDATES: 4D Pharma warns of wind-up; Star Phoenix files claim

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Wednesday and not separately reported by Alliance News:

Read more
1 Jul 2022 20:05

TRADING UPDATES: Capital wins contracts; 4D pharma pauses enrolment

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Friday and not separately reported by Alliance News:

Read more
28 Jun 2022 21:23

IN BRIEF: 4D Pharma shares to be delisted from Nasdaq

4D Pharma PLC - Leeds, England-based pharmaceutical company - Says it has received written notice from the Nasdaq Stock Market that its securities will be delisted from Nasdaq. Accordingly, trading of its shares will be suspended from the opening of business on July 7. Nasdaq staff cited 4D's announcement that it had been placed into administration on Friday as raising "public interest concerns". The exchange also mentioned concerns regarding the residual equity interest of existing shareholders of listed securities.

Read more
24 Jun 2022 19:09

IN BRIEF: 4d Pharma faces uncertain future as loan repayment due

4d Pharma PLC - Leeds, England-based pharmaceutical company - Says it has "no immediate certainty" of how it will repay the USD13.9 million loan facility it has with Oxford Finance LLC.

Read more
24 Jun 2022 14:33

IN BRIEF: 4d Pharma suspends trading immediately, pending announcement

4d Pharma PLC - Leeds, England-based pharmaceutical company - Says it has ordered an immediate suspension of trading in the company's shares on AIM pending a further announcement.

Read more
24 Jun 2022 12:35

4D Pharma requests immediate suspension of its shares

(Sharecast News) - Biotherapeutics developer 4D Pharma requested an immediate suspension of trading in its shares on Friday.

Read more
21 Jun 2022 16:05

UK shareholder meetings calendar - next 7 days

Wednesday 22 June 
ASA International Group PLCAGM
Atalaya Mining PLCAGM
Bonhill Group PLCAGM
Chapel Down Group PLCAGM
Churchill China PLCAGM
Downing Renewables & Infrastructure Trust PLCGM re share issue
Ecofin US Renewables Infrastructure Trust PLCAGM
EJF Investments LtdAGM
Frenkel Topping Group PLCAGM
Good Energy Group PLCAGM
Honeycomb Investment Trust PLCAGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
Intelligent Ultrasound Group PLCAGM
Iofina PLCAGM
John Wood Group PLCAGM
Kingfisher PLCAGM
LXi REIT PLCGM
Menhaden PLCAGM
North Atlantic Smaller Cos Investment Trust PLCAGM
Pennant International Group PLCAGM
Plant Health Care PLCAGM
Skillcast Group PLCAGM
Team PLCAGM
Tribal Group PLCGM re final dividend
Trident Royalties PLCAGM
Vertu Motors PLCAGM
Wentworth Resources PLCAGM
Thursday 23 June 
Avacta Group PLCAGM
Anglo Asian Mining PLCAGM
Card Factory PLCAGM
Cordiant Digital Infrastructure LtdAGM
Downing Renewables & Infrastructure Trust PLCGM re initial placing & open offer
Eight Capital Partners PLCGM re aligning 2022 bonds with 2026 bonds
GENinCode PLCAGM
Ideagen PLCGM re takeover by Hg Pooled Management Ltd
Longboat Energy PLCAGM
Oxford Nanopore Technologies PLCAGM
Puma VCT 13 PLCGM re cancellation of listing & liquidation
RBG Holdings PLCAGM
Tandem Group PLCAGM
Union Jack Oil PLCAGM
Zinnwald Lithium PLCAGM
Friday 24 June 
AFC Energy PLCGM re fees for non-executive directors
Avast PLCAGM
Devolver Digital IncAGM
Entain PLCAGM
Gulf Keystone Petroleum LtdAGM
Hawkwing PLCAGM
Invesco Bond Income Plus LtdAGM
Life Science REITAGM
Northcoders Group PLCAGM
Princess Private Equity Holding LtdAGM
Monday 27 June 
Anglo-Eastern Plantations PLCAGM
Celadon Pharmaceuticals PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Echo Energy PLCAGM
Medica Group PLCAGM
Pelatro PLCAGM
Surgical Innovations Group PLCAGM
Warpaint London PLCAGM
Tuesday 28 June 
4D Pharma PLCAGM
Acceler8 Ventures PLCAGM
Airtel Africa PLCAGM
Alina Holdings PLCAGM
Aquila Energy Efficiency Trust PLCAGM
Attraqt Group PLCAGM
Bay Capital PLCAGM
Capital & Counties Properties PLCAGM
CMO Group PLCAGM
Corre Energy BVAGM
Creo Medical Group PLCAGM
Futura Medical PLCAGM
Gama Aviation PLCAGM
ICG Enterprise Trust PLCAGM
ImmuPharma PLCAGM
IQE PLCAGM
Katoro Gold PLCAGM
Rockhopper Exploration PLCAGM
Sound Energy PLCAGM
TP Group PLCAGM
UK Oil & Gas PLCAGM
Volvere PLCAGM
Zegona Communications PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
27 May 2022 10:46

4D Pharma reports progress in bladder cancer trial

(Sharecast News) - Live biotherapeutics developer 4D Pharma announced progress in the phase 2 clinical trial in bladder cancer on Friday.

Read more
27 May 2022 09:31

IN BRIEF: 4D Pharma plans to test MRx0518 in combination with Bavencio

4D Pharma PLC - Leeds, England-based pharmaceutical company - Plans to conduct a phase II study to assess the safety of MRx0518 in combination with Bavencio. Says the study will be conducted in patients with unresectable locally advanced or metastatic urothelial carcinoma, a type of bladder cancer. Says previous data about MRx0518 supports the potential of this combination to "significantly enhance and improve" outcomes for patients, beyond treatment with Bavencio alone. Bavencio is an antibody medication for the treatment of urothelial carcinoma.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.